·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 22, 2025

In the news: Similar genetics may drive multiple psychiatric conditions, FDA approves oral semaglutide pill, COVID-19 may have link to chronic conditions and more.

Publications & Newsletters
UPDATED
·
2 Min Read

Consumer-driven healthcare: Council on Medical Service reports

Download PDFs of key council reports that advance policies that emphasize patient choice and control of their healthcare by addressing high-value care, retail/store-based clinics, addiction treatment centers, genetic/genomic precision medicine, telemedicine, insurance coverage options, reference pricing, prescription drugs, and hospital care coordination.

Medical Service
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
6 Min Read

Oct. 31, 2025: National Advocacy Update

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy Update.

Advocacy Update
Tired man scrolls through a smartphone in a darkened bedroom
·
4 Min Read

GLP-1s and macular degeneration: Is there a link?

A JAMA Ophthalmology study of 90,000 patients examines that question. Learn more, plus see what else is trending in JAMA Network journals.

Publications & Newsletters
Figure working at desk, surrounded by giant stethoscope and business documents
UPDATED
·
9 Min Read

AMA Advocacy issue briefs

Download PDFs of issue briefs that summarize key health policy issues by providing concise and digestible content for both relevant stakeholders and those who may know little about the topic.

Federal Advocacy
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Sept. 15, 2025

In the news: FDA responds to misleading drug ads, 1 in 6 parents say they skipped or delayed vaccinating children, chagas disease may be endemic in U.S. and more.

Publications & Newsletters
Hands administering semaglutide injection
·
5 Min Read

Spending on GLP-1s has grown dramatically. Here are the details.

Effective GLP-1s marketed under brand names such as Ozempic and Mounjaro have grown popular. That has translated into big dollar figures. 

Behavioral Health
Patient reads a prescription
·
3 Min Read

New FDA opioid labeling keep focus on individualized care

Agency action updates medication risk information and supports prescribing decisions tailored to individual patient needs. 

Behavioral Health